Skip to main content
Top
Published in: BMC Infectious Diseases 1/2015

Open Access 01-12-2015 | Research article

Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India

Authors: Jan P Boettcher, Yubaraj Siwakoti, Ana Milojkovic, Niyamat A Siddiqui, Chitra K Gurung, Suman Rijal, Pradeep Das, Axel Kroeger, Megha R Banjara

Published in: BMC Infectious Diseases | Issue 1/2015

Login to get access

Abstract

Background

To eliminate visceral leishmaniasis (VL) in India and Nepal, challenges of VL diagnosis, treatment and reporting need to be identified. Recent data indicate that VL is underreported and patients face delays when seeking treatment. Moreover, VL surveillance data might not reach health authorities on time. This study quantifies delays for VL diagnosis and treatment, and analyses the duration of VL reporting from district to central health authorities in India and Nepal.

Methods

A cross-sectional study conducted in 12 districts of Terai region, Nepal, and 9 districts of Bihar State, India, in 2012. Patients were interviewed in hospitals or at home using a structured questionnaire, health managers were interviewed at their work place using a semi-structured questionnaire and in-depth interviews were conducted with central level health managers. Reporting formats were evaluated. Data was analyzed using two-tailed Mann-Whitney U or Fisher’s exact test.

Results

92 VL patients having experienced 103 VL episodes and 49 district health managers were interviewed. Patients waited in Nepal 30 days (CI 18-42) before seeking health care, 3.75 times longer than in Bihar (8d; CI 4-12). Conversely, the lag time from seeking health care to receiving a VL diagnosis was 3.6x longer in Bihar (90d; CI 68-113) compared to Nepal (25d; CI 13-38). The time span between diagnosis and treatment was short in both countries. VL reporting time was in Nepal 19 days for sentinel sites and 76 days for “District Public Health Offices (DPHOs)”. In Bihar it was 28 days for “District Malaria Offices”. In Nepal, 73% of health managers entered data into computers compared to 16% in Bihar. In both countries reporting was mainly paper based and standardized formats were rarely used.

Conclusions

To decrease the delay between onset of symptoms and getting a proper diagnosis and treatment the approaches in the two countries vary: In Nepal health education for seeking early treatment are needed while in Bihar the use of private and non-formal practitioners has to be discouraged. Reinforcement of VL sentinel reporting in Bihar, reorganization of DPHOs in Nepal, introduction of standardized reporting formats and electronic reporting should be conducted in both countries.
Appendix
Available only for authorised users
Literature
1.
go back to reference WHO Regional Office for South-East Asia, Regional Technical Advisory Group (RTAG) on Kala-azar Elimination. Report of the Third RTAG Meeting. In: Meeting reports. New Delhi, India: WHO SEARO; 2009. WHO Regional Office for South-East Asia, Regional Technical Advisory Group (RTAG) on Kala-azar Elimination. Report of the Third RTAG Meeting. In: Meeting reports. New Delhi, India: WHO SEARO; 2009.
2.
go back to reference WHO Regional Office for South-East Asia, Regional Technical Advisory Group (RTAG) on Kala-azar Elimination. Report of the Fourth RTAG Meeting. In: Meeting reports. New Delhi, India: WHO SEARO; 2011. WHO Regional Office for South-East Asia, Regional Technical Advisory Group (RTAG) on Kala-azar Elimination. Report of the Fourth RTAG Meeting. In: Meeting reports. New Delhi, India: WHO SEARO; 2011.
3.
go back to reference Joshi A, Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, et al. Can visceral leishmaniasis be eliminated from Asia? J Vector Borne Dis. 2008;45(2):105–11.PubMed Joshi A, Narain JP, Prasittisuk C, Bhatia R, Hashim G, Jorge A, et al. Can visceral leishmaniasis be eliminated from Asia? J Vector Borne Dis. 2008;45(2):105–11.PubMed
4.
go back to reference Singh SP, Reddy DC, Rai M, Sundar S. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar. India Trop Med Int Health. 2006;11(6):899–905.CrossRefPubMed Singh SP, Reddy DC, Rai M, Sundar S. Serious underreporting of visceral leishmaniasis through passive case reporting in Bihar. India Trop Med Int Health. 2006;11(6):899–905.CrossRefPubMed
6.
go back to reference Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, et al. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg. 2010;83(3):507–11.CrossRefPubMedPubMedCentral Hirve S, Singh SP, Kumar N, Banjara MR, Das P, Sundar S, et al. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal. Am J Trop Med Hyg. 2010;83(3):507–11.CrossRefPubMedPubMedCentral
7.
go back to reference Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, et al. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis. 2009;3(1):e355.CrossRefPubMedPubMedCentral Mondal D, Singh SP, Kumar N, Joshi A, Sundar S, Das P, et al. Visceral leishmaniasis elimination programme in India, Bangladesh, and Nepal: reshaping the case finding/case management strategy. PLoS Negl Trop Dis. 2009;3(1):e355.CrossRefPubMedPubMedCentral
8.
go back to reference Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ. 2006;333(7571):723.CrossRefPubMedPubMedCentral Chappuis F, Rijal S, Soto A, Menten J, Boelaert M. A meta-analysis of the diagnostic performance of the direct agglutination test and rK39 dipstick for visceral leishmaniasis. BMJ. 2006;333(7571):723.CrossRefPubMedPubMedCentral
9.
go back to reference Government of Nepal - Ministry of Health and Population: Kala-azar Elimination Program in Nepal. National Strategic Guideline on Kala-azar Elimination Program in Nepal 2009 2009. Government of Nepal - Ministry of Health and Population: Kala-azar Elimination Program in Nepal. National Strategic Guideline on Kala-azar Elimination Program in Nepal 2009 2009.
10.
go back to reference Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis. 2011;11(4):322–5.CrossRefPubMed Matlashewski G, Arana B, Kroeger A, Battacharya S, Sundar S, Das P, et al. Visceral leishmaniasis: elimination with existing interventions. Lancet Infect Dis. 2011;11(4):322–5.CrossRefPubMed
11.
go back to reference Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873–82.CrossRefPubMed Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW, et al. Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol. 2007;5(11):873–82.CrossRefPubMed
12.
go back to reference Pascual Martinez F, Picado A, Roddy P, Palma P. Low castes have poor access to visceral leishmaniasis treatment in Bihar, India. Trop Med Int Health. 2012;17(5):666–73.CrossRefPubMed Pascual Martinez F, Picado A, Roddy P, Palma P. Low castes have poor access to visceral leishmaniasis treatment in Bihar, India. Trop Med Int Health. 2012;17(5):666–73.CrossRefPubMed
13.
go back to reference Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, et al. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis. 2010; 4(10). doi:10.1371/journal.pntd.0000832 Mondal D, Nasrin KN, Huda MM, Kabir M, Hossain MS, Kroeger A, et al. Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Negl Trop Dis. 2010; 4(10). doi:10.1371/journal.pntd.0000832
14.
go back to reference Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, et al. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis. 2011;5(2):e960.CrossRefPubMedPubMedCentral Singh SP, Hirve S, Huda MM, Banjara MR, Kumar N, Mondal D, et al. Options for active case detection of visceral leishmaniasis in endemic districts of India, Nepal and Bangladesh, comparing yield, feasibility and costs. PLoS Negl Trop Dis. 2011;5(2):e960.CrossRefPubMedPubMedCentral
15.
go back to reference Pyle DF, Nath LM, Shrestha BL, Sharma A, Koirala S. Assessment of Early Warning and Reporting Systems (EWARS) in NEPAL. In: Environmental Health Project - Activity Reports. Edited by USAID, vol. 126. Washington, DC 20523, USA; 2004. Pyle DF, Nath LM, Shrestha BL, Sharma A, Koirala S. Assessment of Early Warning and Reporting Systems (EWARS) in NEPAL. In: Environmental Health Project - Activity Reports. Edited by USAID, vol. 126. Washington, DC 20523, USA; 2004.
16.
go back to reference Epidemiology and Disease Control Division: Weekly Epidemiological Bulletin No. 24. In: Weekly Epidemiological Bulletins. Edited by Department of Health Services - Ministry of Health and Population, vol. 24. Kathmandu, Nepal; 2012. Epidemiology and Disease Control Division: Weekly Epidemiological Bulletin No. 24. In: Weekly Epidemiological Bulletins. Edited by Department of Health Services - Ministry of Health and Population, vol. 24. Kathmandu, Nepal; 2012.
17.
go back to reference Lehmann EL, D'Abrera HJM. Nonparametrics: statistical methods based on ranks: Holden-Day. New York, USA: McGraw-Hill; 1975. Lehmann EL, D'Abrera HJM. Nonparametrics: statistical methods based on ranks: Holden-Day. New York, USA: McGraw-Hill; 1975.
18.
go back to reference Bern C, Courtenay O, Alvar J. Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis. 2010;4(2):e599.CrossRefPubMedPubMedCentral Bern C, Courtenay O, Alvar J. Of cattle, sand flies and men: a systematic review of risk factor analyses for South Asian visceral leishmaniasis and implications for elimination. PLoS Negl Trop Dis. 2010;4(2):e599.CrossRefPubMedPubMedCentral
19.
go back to reference Bhunia GS, Chatterjee N, Kumar V, Siddiqui NA, Mandal R, Das P, et al. Delimitation of kala-azar risk areas in the district of Vaishali in Bihar (India) using a geo-environmental approach. Mem Inst Oswaldo Cruz. 2012;107(5):609–20.CrossRefPubMed Bhunia GS, Chatterjee N, Kumar V, Siddiqui NA, Mandal R, Das P, et al. Delimitation of kala-azar risk areas in the district of Vaishali in Bihar (India) using a geo-environmental approach. Mem Inst Oswaldo Cruz. 2012;107(5):609–20.CrossRefPubMed
20.
go back to reference Bhunia GS, Kesari S, Chatterjee N, Kumar V, Das P. Localization of kala-azar in the endemic region of Bihar, India based on land use/land cover assessment at different scales. Geospat Health. 2012;6(2):177–93.CrossRefPubMed Bhunia GS, Kesari S, Chatterjee N, Kumar V, Das P. Localization of kala-azar in the endemic region of Bihar, India based on land use/land cover assessment at different scales. Geospat Health. 2012;6(2):177–93.CrossRefPubMed
21.
go back to reference Mishra RN, Singh SP, Vanlerberghe V, Sundar S, Boelaert M, Lefevre P. Lay perceptions of kala-azar, mosquitoes and bed nets in Bihar, India. Trop Med Int Health. 2010;15 Suppl 2:36–41.CrossRefPubMed Mishra RN, Singh SP, Vanlerberghe V, Sundar S, Boelaert M, Lefevre P. Lay perceptions of kala-azar, mosquitoes and bed nets in Bihar, India. Trop Med Int Health. 2010;15 Suppl 2:36–41.CrossRefPubMed
22.
go back to reference Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VN, Verma RB, et al. Awareness about kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India. Southeast Asian J Trop Med Public Health. 2010;41(1):1–12.PubMed Siddiqui NA, Kumar N, Ranjan A, Pandey K, Das VN, Verma RB, et al. Awareness about kala-azar disease and related preventive attitudes and practices in a highly endemic rural area of India. Southeast Asian J Trop Med Public Health. 2010;41(1):1–12.PubMed
23.
go back to reference Asian Development Bank, State of Bihar: Bihar State Highways II Project. In: Project Agreements. Edited by Asian Development Bank, vol. IND 41629. Mandaluyong City 1550, Philippines; 2010. Asian Development Bank, State of Bihar: Bihar State Highways II Project. In: Project Agreements. Edited by Asian Development Bank, vol. IND 41629. Mandaluyong City 1550, Philippines; 2010.
24.
go back to reference Sundar S, Chakravarty J. Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India. 2012;25(2):85–9.PubMed Sundar S, Chakravarty J. Recent advances in the diagnosis and treatment of kala-azar. Natl Med J India. 2012;25(2):85–9.PubMed
25.
go back to reference Banjara MR, Siddhivinayak H, Niyamat Ali S, Narendra K, Sangeeta K, Huda MM, et al. Visceral Leishmaniasisclinical management in endemic districts of India, Nepal and Bangladesh. J Trop Med. 2012;2012:126093.CrossRefPubMedPubMedCentral Banjara MR, Siddhivinayak H, Niyamat Ali S, Narendra K, Sangeeta K, Huda MM, et al. Visceral Leishmaniasisclinical management in endemic districts of India, Nepal and Bangladesh. J Trop Med. 2012;2012:126093.CrossRefPubMedPubMedCentral
26.
go back to reference Gill R, Stewart DE. Relevance of gender-sensitive policies and general health indicators to compare the status of South Asian women's health. Womens Health Issues. 2011;21(1):12–8.CrossRefPubMed Gill R, Stewart DE. Relevance of gender-sensitive policies and general health indicators to compare the status of South Asian women's health. Womens Health Issues. 2011;21(1):12–8.CrossRefPubMed
27.
go back to reference UNDP. Human development report 2011 sustainability and equity: a better future for all. New York, NY 10017, USA: United Nations Development Programme 1 UN Plaza; 2011.CrossRef UNDP. Human development report 2011 sustainability and equity: a better future for all. New York, NY 10017, USA: United Nations Development Programme 1 UN Plaza; 2011.CrossRef
28.
go back to reference WHO Regional Office for South-East Asia: Technical Consultation with Partners for Elimination of Kala-azar in Endemic Countries of WHO SEA. In: Technical Consultation Reports. Edited by WHO SEARO, vol. SEA–VBC–90. New Delhi, India; 2006. WHO Regional Office for South-East Asia: Technical Consultation with Partners for Elimination of Kala-azar in Endemic Countries of WHO SEA. In: Technical Consultation Reports. Edited by WHO SEARO, vol. SEA–VBC–90. New Delhi, India; 2006.
29.
go back to reference Ostyn B, Malaviya P, Hasker E, Uranw S, Singh RP, Rijal S, et al. Retrospective quarterly cohort monitoring for patients with visceral leishmaniasis in the Indian subcontinent: outcomes of a pilot project. Trop Med Int Health. 2013;18(6):725–33.CrossRefPubMed Ostyn B, Malaviya P, Hasker E, Uranw S, Singh RP, Rijal S, et al. Retrospective quarterly cohort monitoring for patients with visceral leishmaniasis in the Indian subcontinent: outcomes of a pilot project. Trop Med Int Health. 2013;18(6):725–33.CrossRefPubMed
Metadata
Title
Visceral leishmaniasis diagnosis and reporting delays as an obstacle to timely response actions in Nepal and India
Authors
Jan P Boettcher
Yubaraj Siwakoti
Ana Milojkovic
Niyamat A Siddiqui
Chitra K Gurung
Suman Rijal
Pradeep Das
Axel Kroeger
Megha R Banjara
Publication date
01-12-2015
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2015
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-015-0767-5

Other articles of this Issue 1/2015

BMC Infectious Diseases 1/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine